Skip to main content
The Bright Side
arrow_backHome
The healthcare system returns to normal, except for hospitals in the north
Health
Ynet HealthHE
April 8, 2026

The healthcare system returns to normal, except for hospitals in the north

Hospitals are returning to normal and the departments will return to their original locations in the morning hours, however hospitals in the north will continue to operate for the time being in a limited format in parking lots and protected complexes below ground level – according to the civil defense policy of the Home Front Command. Sheba Medical Center has already begun to bring back the women's, maternity and children's departments from the underground.

Read More
translateRead translated

Automatic translation by Google

Curated from Ynet Health. Classified as Health by AI, which sometimes makes mistakes.

Why are you reporting this article?

Why are you reporting this article?
0/500

More like this

More
Walla! Health News8/27/2026

With full genomic sequencing at Sheba: the revolutionary technology that eliminates excess weight and extends life by up to an additional 30 years

23 years after the Human Genome Project was completed, Israeli scientists have succeeded in translating this knowledge into a technology that allows every person to lose weight permanently, be saved from thousands of diseases, including 50 types of cancer, and extend life by several decades. Prof. Barbash: "We are at a turning point in medicine"

Ynet Health8/27/2026

"I couldn't believe it": Innovative blood test raised suspicion of cancer — and imaging revealed a lung mass

Large-scale research found that combining the “Grail” blood test with standard screening examinations could increase the number of detected cancer cases fourfold. The same happened to Peter, a retired police officer from England, who, following the test and subsequent diagnostic examinations, discovered that he is developing lung cancer. “I had no symptoms at all. I didn't feel sick,” he says. The “Grail” test is an innovative blood test designed to detect signals of 50 types of cancer before symptoms appear.